Antibody Drug Complexes (ADCs): A Promising Cancer Treatment with Ocular Toxicity Risks
Antibody-Drug Conjugates (ADCs): A Breakthrough in Cancer Treatment wiht Ocular Toxicity Risks Antibody-Drug Conjugates (ADCs) represent a groundbreaking advancement in cancer therapy, combining teh precision of monoclonal antibodies with the potency of chemotherapy drugs.As studies highlight, these targeted therapies aim to deliver cytotoxic agents directly to tumor cells, minimizing systemic toxicity. However, emerging research … Read more